Connect with us
[ad_1] Newswise — SAN DIEGO – Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct...
[ad_1] Newswise — PHILADELPHIA—For his work discovering the basis for hemoglobin gene switching and applying those insights to develop a therapy for sickle cell disease and...
[ad_1] Newswise — CHICAGO – Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many...
[ad_1] Newswise — PHILADELPHIA – Two esteemed leaders from the Penn Medicine Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will...
[ad_1] Newswise — PHILADELPHIA—Penn Medicine is launching a new community mental health hub at the Hospital of the University of Pennsylvania — Cedar Avenue (HUP Cedar),...
[ad_1] Newswise — PHILADELPHIA— A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to...
[ad_1] Newswise — PHILADELPHIA— Penn Medicine has received a $9.7 million grant from The Warren Alpert Foundation (WAF) that will fund continuing education efforts for genetic...
[ad_1] Newswise — PHILADELPHIA – Penn Medicine has partnered with the Howley Foundation and La Salle University to launch the ASPIRE Program at the Hospital of...
[ad_1] Newswise — PHILADELPHIA—The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds...
[ad_1] Newswise — NEW ORLEANS – A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow...
[ad_1] Newswise — NEW ORLEANS – Researchers from the University of Pennsylvania’s Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating...
[ad_1] Newswise — PHILADELPHIA—Adults with a genetic form of childhood-onset blindness experienced striking recoveries of night vision within days of receiving an experimental gene therapy, according...